Gemcitabine, Ascorbate, Radiation Therapy for Pancreatic Cancer, Phase I
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Ascorbic acid (Primary) ; Gemcitabine
- Indications Pancreatic cancer
- Focus Adverse reactions
- 04 Jun 2021 Biomarkers information updated
- 12 Dec 2013 Planned End Date changed from 1 Dec 2017 to 1 Feb 2018.as reported by ClinicalTrials.gov.
- 12 Dec 2013 Planned initiation date changed from 1 Dec 2013 to 1 Feb 2014 as reported by ClinicalTrials.gov.